The EU has lost a legal bid to force AstraZeneca to get the Covid-19 vaccine or accelerate risk Billions of euros fineThe latest round of fierce battles between Brock and the UK-Swedish pharmaceutical companies.
In a Friday ruling, a Brussels court criticized a “serious breach” of the contract with the EU after repeated shortages of AstraZeneca, but refused to impose the new schedule required by Brussels. In the case of June, or pay a fine of € 10 per daily dose.
The dispute between the European Commission and AstraZeneca is serious Damaged the position of the company It swirled into a diplomatic line with the continent in February when Brussels threatened to exercise the urgent provisions of the Brexit agreement to block vaccines entering Britain via Northern Ireland.
A court in Brussels ruled that AstraZeneca should provide a dose of 80 m by the end of September. However, in reality, this does not affect AstraZeneca. AstraZeneca has already delivered a dose of 70m and will provide the remaining 10m by the end of this month.
The Commission argues that the court’s ruling still puts pressure on AstraZeneca as it “lays the groundwork for future dose delivery on the basis of clear contractual principles,” including supply from the UK manufacturing site. did.
“Companies need to follow these paths and can no longer claim that they can no longer use British plants for the production of vaccines in the European Union,” the Commission said.
The ruling is that of a pharmaceutical company Failure to send EU vaccine Manufactured in the United Kingdom was inconsistent with making “best reasonable efforts” on the supply required for the contract. However, it did not order AstraZeneca to use British production to meet EU orders.
Nonetheless, the UK plant operated by the Oxford BioMedica plant will begin manufacturing for the EU, a person familiar with the matter said.
AstraZeneca was initially expected to supply the EU with up to 300 million doses in the first six months of this year, but production problems have significantly reduced that forecast.
The pace of EU vaccine deployment has improved, primarily using Pfizer / BioNTech and Moderna jabs, and some countries have since imposed restrictions on AstraZeneca vaccines. Discovery of a rare blood clot, There is not much practical need for dosage.
Jeffrey Pott, AstraZeneca’s legal counsel, said: And from the deadliest pandemic of a generation in the world. “
Ursula von der Leyen, President of the Commission, said: It’s nice to see an independent judge confirm this. “
EU fails legal bid to speed up AstraZeneca’s vaccine supply
Source link EU fails legal bid to speed up AstraZeneca’s vaccine supply